Fingerprint
Dive into the research topics of 'Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically